Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 1849-1860 of 22361

The AI Summit London Unveils 10th Anniversary Speaker Line-Up Featuring Global Leaders in Enterprise AI

MOVIVA® launch spotlight at ESGE Days 2026

Porta Nuova, Milan - LEED v4.1 Communities: Existing, Gold certification. Photo courtesy of COIMA.

Resilience Takes Center Stage as Europe’s LEED Community Gathers in Milan for GBCI Europe Circle 2026

Bernard Blerot, VP R&D Naturals at IFF, smelling geranium in a botanical research laboratory.

LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery

Global commerce intelligence platform delivers high employee satisfaction with Navan

Criteo Selects Navan to Modernize Global Travel Management

Saba Capital Secures Major Liquidity Win for Herald Investment Trust Shareholders, Marking Sixth Successful Outcome of Seven Original UK Campaigns

Apis Partners Announces Final Close of $1.23 Billion Fund III, Double its Predecessor

Urethral stricture starts with narrowing of a short segment of urethral lumen. At early stages, it is managed by balloon dilatation or DVIU Urethrotomy. The open urethrotomy wound after dilatation or DVIU has to heal from the edges of the wound, which may take a longer time. In BEES-HAUS cell therapy, the cell transplant having proven successful engraftment, covering the urethrotomy wound, yielding clinical safety and efficacy may be considered to be included in the treatment guidelines after validation. Its simplified version, the BHES-HAUS (Buccal epithelium Hashed and Encapsulated in Scaffold—Hybrid Approach to Urethral Stricture) accomplished in one-go without need for cell culture in a lab, works on similar principles. After long term follow-up, BHES-HAUS minimally invasive approach may be worth combining with DVIU and balloon dilatation, as it may be able to provide longer duration of recurrence-free, good quality of life without need for intermittent self-catheterization.

Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES-HAUS’ results to be presented in AUA 2026

Business Wire

The AI Summit London Unveils 10th Anniversary Speaker Line-Up Featuring Global Leaders in Enterprise AI

MOVIVA® launch spotlight at ESGE Days 2026

Resilience Takes Center Stage as Europe’s LEED Community Gathers in Milan for GBCI Europe Circle 2026

LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery

Criteo Selects Navan to Modernize Global Travel Management

Saba Capital Secures Major Liquidity Win for Herald Investment Trust Shareholders, Marking Sixth Successful Outcome of Seven Original UK Campaigns

Apis Partners Announces Final Close of $1.23 Billion Fund III, Double its Predecessor

Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES-HAUS’ results to be presented in AUA 2026

Interactive Brokers Launches Access to Korean Equities, Breaking New Ground for Global Investors

Brightfin Launches Spend Clearly AI to Help Enterprise Tech Leaders Take Control of Growing IT and AI Costs

Arm Holdings plc Reports Results for the Fourth Quarter and Fiscal Year Ended 2026

iQmetrix to Showcase Intelligent Commerce Operating System and Catalyst Innovation at DTW Ignite 2026